124 related articles for article (PubMed ID: 22956196)
1. Bridging the gap between a TB drug and its target.
Cook GM; Heikal A
Sci Transl Med; 2012 Sep; 4(150):150fs33. PubMed ID: 22956196
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis.
Neres J; Pojer F; Molteni E; Chiarelli LR; Dhar N; Boy-Röttger S; Buroni S; Fullam E; Degiacomi G; Lucarelli AP; Read RJ; Zanoni G; Edmondson DE; De Rossi E; Pasca MR; McKinney JD; Dyson PJ; Riccardi G; Mattevi A; Cole ST; Binda C
Sci Transl Med; 2012 Sep; 4(150):150ra121. PubMed ID: 22956199
[TBL] [Abstract][Full Text] [Related]
4. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones.
Nosova EV; Lipunova GN; Charushin VN; Chupakhin ON
Mini Rev Med Chem; 2019; 19(12):999-1014. PubMed ID: 30324881
[TBL] [Abstract][Full Text] [Related]
7. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
8. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
[TBL] [Abstract][Full Text] [Related]
9. Identification of antitubercular benzothiazinone compounds by ligand-based design.
Karoli T; Becker B; Zuegg J; Möllmann U; Ramu S; Huang JX; Cooper MA
J Med Chem; 2012 Sep; 55(17):7940-4. PubMed ID: 22916795
[TBL] [Abstract][Full Text] [Related]
10. DprE1--from the discovery to the promising tuberculosis drug target.
Mikusová K; Makarov V; Neres J
Curr Pharm Des; 2014; 20(27):4379-403. PubMed ID: 24245764
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitubercular screening of some novel 4H-1,4- benzothiazines and their sulfones under environment benign solvent free conditions as future anti-tubercular agents.
Guleria A; Jangid DK; Gautam N; Lakhotia R; Chowdhary A; Gautam DC
Comb Chem High Throughput Screen; 2015; 18(1):48-52. PubMed ID: 25426761
[TBL] [Abstract][Full Text] [Related]
12. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
[TBL] [Abstract][Full Text] [Related]
13. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
Makarov V; Manina G; Mikusova K; Möllmann U; Ryabova O; Saint-Joanis B; Dhar N; Pasca MR; Buroni S; Lucarelli AP; Milano A; De Rossi E; Belanova M; Bobovska A; Dianiskova P; Kordulakova J; Sala C; Fullam E; Schneider P; McKinney JD; Brodin P; Christophe T; Waddell S; Butcher P; Albrethsen J; Rosenkrands I; Brosch R; Nandi V; Bharath S; Gaonkar S; Shandil RK; Balasubramanian V; Balganesh T; Tyagi S; Grosset J; Riccardi G; Cole ST
Science; 2009 May; 324(5928):801-4. PubMed ID: 19299584
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.
Gao C; Ye TH; Wang NY; Zeng XX; Zhang LD; Xiong Y; You XY; Xia Y; Xu Y; Peng CT; Zuo WQ; Wei Y; Yu LT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4919-22. PubMed ID: 23886691
[TBL] [Abstract][Full Text] [Related]
15. Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors.
Mathew B; Srivastava S; Ross LJ; Suling WJ; White EL; Woolhiser LK; Lenaerts AJ; Reynolds RC
Bioorg Med Chem; 2011 Dec; 19(23):7120-8. PubMed ID: 22024272
[TBL] [Abstract][Full Text] [Related]
16. A new antituberculosis drug that selectively kills nonmultiplying Mycobacterium tuberculosis.
Mitchison DA
Cell Host Microbe; 2008 Mar; 3(3):122-4. PubMed ID: 18329610
[TBL] [Abstract][Full Text] [Related]
17. New tuberculosis drugs on the horizon.
Cole ST; Riccardi G
Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
[TBL] [Abstract][Full Text] [Related]
18. QSAR, docking studies of 1,3-thiazinan-3-yl isonicotinamide derivatives for antitubercular activity.
Chitre TS; Asgaonkar KD; Patil SM; Kumar S; Khedkar VM; Garud DR
Comput Biol Chem; 2017 Jun; 68():211-218. PubMed ID: 28411471
[TBL] [Abstract][Full Text] [Related]
19. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
Martins M; Viveiros M; Couto I; Amaral L
Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
[TBL] [Abstract][Full Text] [Related]
20. Anti-dormant mycobacterial activity and target analysis of nybomycin produced by a marine-derived Streptomyces sp.
Arai M; Kamiya K; Pruksakorn P; Sumii Y; Kotoku N; Joubert JP; Moodley P; Han C; Shin D; Kobayashi M
Bioorg Med Chem; 2015 Jul; 23(13):3534-41. PubMed ID: 25934225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
